Latest Shareholders News

Duxton Farms returned to positive operating cash flow in the September quarter, but its balance sheet remains stretched with a $13.98 million net overdraft and $103.25 million of drawn financing. A secured convertible note raise and a delayed asset sale are now central to the company’s funding position.

CZR Resources has extended gold mineralisation at Croydon, including its strongest Top Camp result to date, while high-grade iron sampling adds momentum across its Pilbara portfolio. But the company’s proposed Zuleika Gold takeover has run into a shareholder approval failure and now requires ASIC consent to be withdrawn.

Critica has put a combined after-tax NPV of about A$3.0 billion across its Mt Lindsay and Jupiter projects, but ended September with just A$3.3 million in cash. Both developments remain at scoping-study stage and require substantial funding that has not yet been secured.

OMG Group has confirmed its first positive quarterly EBITDA, with Q1 FY27 sales rising 59% to approximately $1.92 million and gross profit growing faster than revenue. The result marks an earnings milestone, but operating cash flow remained negative as the company invested heavily in inventory and supplier deposits.

Sultan Resources has ended the September quarter with $1.652 million in cash as it builds a copper-gold exploration portfolio spanning Namibia and New South Wales. The company’s most advanced near-term work remains contingent on a licence grant, geophysical reviews and shareholder approvals.

HITIQ has expanded its military research ambitions and added fresh funding during the September quarter, but the company ended the period with $658,242 in cash and estimated funding for only one quarter. Its US collaboration remains non-binding, leaving financing and commercial execution as the immediate tests.

Noble Helium has completed the groundwork for its Kinambo drilling campaign in Tanzania, but the program remains paused after wireline contractor SLB was delayed on another project. The company ended September with A$3.905 million in cash, equivalent to an estimated 1.61 quarters of funding at current outgoings, while expanding into Western Australia through the completed Earth Source Hydrogen acquisition.

Macallum New Energy has expanded its Perth Basin exploration inventory, secured commitments for an approximately A$3 million placement and begun seeking a partner to help fund up to two wells in late 2027. The immediate constraint is clear: cash stood at A$0.815 million at quarter-end, equivalent to only 0.8 quarters of funding before the raise.

OzAurum Resources has strengthened the technical case for a low-capex heap leach operation at Mulgabbie North, with column testing delivering up to 95% gold recovery. But the project’s next phase is now tied to a capital raise after cash fell to A$542,000, equivalent to just 0.8 quarters of estimated funding.

OncoSil Medical enters FY27 with FDA approval for its cancer device, rising quarterly revenue and fresh institutional funding, but its U.S. opportunity still depends on reimbursement and a tightly controlled initial rollout. Cash rose to A$8.7 million after the capital raise, while operating cash use remained substantial.

Australian Dairy Nutritionals has secured firm commitments for a further A$1.54 million placement, taking its broader capital raise to A$2.04 million before costs. The funds are earmarked for operations, working capital and balance sheet support as the company prepares for FY27.

Vitasora Health has signed a Florida healthcare agreement covering an initially addressable 9,000 Medicare patients while estimated October billable care minutes rose 50%. The ASX-listed company also agreed terms for an A$3 million secured facility, but the funding is not yet drawn and carries approval, interest and dilution conditions.